Disclosed positions

Estimated from their latest filings — positions may have changed since

$7.87M

combined est. value

Stock	Shares	Price	Value	Weight	As of
NVCRNovoCure Ltd	440,208	$17.88	$7.87M	100%	2026-03-02

NVCR

NovoCure Ltd

$7.87M

440,208 sh

Activity

Open-market buy & sell volume

BuySell

Total +$996.9K bought

Most bought

NVCR

$996.9K

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 1sells 0

Stock	Transaction	Date	~6mo later
NVCRNovoCure Ltd	Tax $98.8K · 7,228 sh	2026-03-02	—
NVCRNovoCure Ltd	Tax $32.9K · 2,410 sh	2026-03-02	—
NVCRNovoCure Ltd	Grant — · 23,818 sh	2026-02-28	—
NVCRNovoCure Ltd	Tax $158.7K · 11,541 sh	2026-02-27	—
NVCRNovoCure Ltd	Buy $996.9K · 81,550 sh	2025-09-05	+11.3%
NVCRNovoCure Ltd	Grant $12.6K · 833 sh	2025-06-30	—

NVCRTax

2026-03-02 · NovoCure Ltd

$98.8K

—

NVCRTax

2026-03-02 · NovoCure Ltd

$32.9K

—

NVCRGrant

2026-02-28 · NovoCure Ltd

23,818

—

NVCRTax

2026-02-27 · NovoCure Ltd

$158.7K

—

NVCRBuy

2025-09-05 · NovoCure Ltd

$996.9K

+11.3%

NVCRGrant

2025-06-30 · NovoCure Ltd

$12.6K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.